How does cocaine-induced pulmonary injury differ from cocaine-induced cardiac injury, and what are the respective acute management strategies?

Cocaine Lung vs Cocaine Heart: Key Differences and Management

Cocaine-induced pulmonary injury ("crack lung") presents as an acute respiratory syndrome with hypoxemia, hemoptysis, respiratory failure, and diffuse pulmonary infiltrates after inhalation, while cocaine-induced cardiac injury manifests primarily as acute coronary syndrome, arrhythmias, and myocardial infarction occurring most commonly within 3 hours of use, with a 24-fold increased MI risk in the first hour. 1

Pathophysiology: Distinct Mechanisms

Cocaine Heart (Cardiac Toxicity)

• Mechanism: Coronary vasoconstriction through catecholamine reuptake inhibition (α-adrenergic receptor agonism) combined with sodium and potassium channel blockade causing QRS prolongation and dysrhythmias 2
• Timing: Two-thirds of MIs occur within 3 hours of cocaine ingestion, though delayed presentations up to 4 days can occur due to persistent cocaine metabolites causing recurrent vasoconstriction 1
• Incidence: 0.7-6% of cocaine users presenting with chest pain develop MI, with average age only 38 years 1

Cocaine Lung (Pulmonary Toxicity)

• Mechanism: Direct cellular toxicity, eosinophilia, barotrauma, and vasoactive effects causing diffuse alveolar hemorrhage, intra-alveolar edema, and foreign body granuloma formation 3, 4
• Presentation: Acute bilateral pulmonary infiltrates, hemoptysis, hypoxemia progressing to ARDS in severe cases 1, 4
• Route-specific: Occurs after inhalation of freebase cocaine (crack), with lungs as principal exposed organs 4

Clinical Presentation: How to Distinguish

Cardiac Presentation

• Pressure-like chest pain (most common symptom in 56% of users) 1
• Dyspnea (60%) and diaphoresis (40%) 1
• Critical caveat: Only 44% of cocaine-associated MIs report antecedent chest pain, making chest pain unreliable for discriminating ischemic from non-ischemic causes 1
• Arrhythmias occur in 43% (ventricular tachycardia 18%, bradyarrhythmia 20%) 1
• Must exclude aortic dissection (37% association in one urban center study, though IRAD registry shows only 0.5% overall) 1

Pulmonary Presentation

• Intense cough, hemoptysis, chest pain with acute bilateral infiltrates 4
• Hypoxemia and respiratory failure 1
• Focal or diffuse alveolar hemorrhage on imaging 3
• Can mimic malignancy on imaging, requiring temporal correlation with cocaine use 3
• Pneumomediastinum, pneumothorax, and pneumopericardium from barotrauma 5

Acute Management Strategies

Cocaine Heart Management (Based on AHA 2008 & 2023 Guidelines)

First-line therapy:

1. Benzodiazepines - Mainstay for blood pressure control and psychomotor agitation 2, 6

   • Limitation: May not always effectively mitigate tachycardia, hypertension, and vasospasm (8 treatment failures in 234 subjects) 6

2. Aspirin - Standard acute coronary syndrome protocol 7

3. Nitroglycerin - For coronary vasospasm 2, 6

   • Caveat: Can cause severe hypotension and reflex tachycardia (11 treatment failures, 2 adverse events in 246 subjects) 6

Second-line therapy: 4. Calcium channel blockers (Class 2a recommendation) - For severe hypertension and coronary vasospasm 2, 6

• Effective for hypertension/vasospasm but not necessarily tachycardia 6

1. Phentolamine (α1-blocker) (Class 2a recommendation) - For refractory coronary vasospasm and hypertensive emergencies 2, 6

2. Sodium bicarbonate (Class 2a recommendation) - For wide-complex tachycardia or cardiac arrest 2

3. Lidocaine (Class 2a recommendation) - For wide-complex tachycardia through competitive sodium channel binding 2

Critical management pitfalls:

• β-blockers controversy: Evidence shows both benefit and harm; combined β/α-blockers (labetalol, carvedilol) appear safer with no adverse events reported and effective for both hypertension and tachycardia 6
• Fibrinolytic agents: Controversial due to limited evidence 7
• Hyperthermia: Requires rapid external cooling (evaporative or immersive, NOT cooling blankets) (Class 1 recommendation) 2

Cocaine Lung Management

Primary approach: Conservative supportive care

1. Immediate cocaine cessation 4
2. Symptomatic therapy with oxygen support 4
3. Observation - Most cases improve rapidly with discontinuation 4
4. Mechanical ventilation if progressing to ARDS 1, 4

Diagnostic considerations:

• Bronchoalveolar lavage shows polymorphonuclear neutrophil infiltration and foreign body granulomas 4
• High-resolution CT to exclude esophageal rupture if pneumomediastinum present 5
• Serial imaging to document resolution and exclude malignancy 3

Key difference from cardiac management: No specific pharmacologic interventions required; resolution occurs with abstinence and supportive care 3, 4

Prognosis and Complications

Cardiac

• 38% develop cardiac complications, 90% within first 12 hours 1
• In-hospital mortality 0% in one study, but better cardiac arrest survival (46% vs 78% in controls) 1
• Long-term risk: 58% recurrent ischemic events with continued use; 60% continue cocaine use after discharge 1
• Continued use leads to 1.6% nonfatal MI rate at 30 days 1

Pulmonary

• Rapid improvement with cocaine discontinuation 4
• Can progress to ARDS if untreated 4
• Complete radiological resolution possible with conservative management 3, 5

Critical Decision Algorithm

Patient presents with chest pain + cocaine use:

1. Obtain ECG immediately - Look for QRS prolongation, ST changes
2. Assess respiratory status - Hypoxemia, hemoptysis, bilateral infiltrates suggest pulmonary
3. Timing matters - <3 hours = highest cardiac risk; respiratory symptoms = pulmonary
4. Imaging: CXR for infiltrates; consider CT for aortic dissection if severe pain
5. If cardiac suspected: Benzodiazepines → Nitroglycerin → Consider CCB/phentolamine → Sodium bicarbonate if wide QRS
6. If pulmonary suspected: Supportive care, oxygen, observe for ARDS progression
7. Both can coexist - Pulmonary hypertension from cocaine can cause chest pain and dyspnea 1